---
figid: PMC7937683__41418_2020_628_Fig8_HTML
figtitle: Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance
  to EGFR-targeted therapy through Src kinase activation
organisms:
- Homo sapiens
- Mus musculus
- Armoracia rusticana
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7937683
filename: 41418_2020_628_Fig8_HTML.jpg
figlink: pmc/articles/PMC7937683/figure/Fig8/
number: F8
caption: a Dsg2 functions as a tumor suppressor through binding between the Dsg2 IL
  domain and cSrc SH2 domain. The EGFR-targeted therapy suppresses EGFR signaling
  pathway. b The loss of Dsg2 in GBC activates cSrc and promotes EGFR internalization,
  which induces resistance to EGFR-targeted therapy. c Combination therapy targeting
  both cSrc and EGFR is a promising therapeutic strategy for GBC patients with Dsg2
  loss.
papertitle: Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance
  to EGFR-targeted therapy through Src kinase activation.
reftext: Sang-Hyun Lee, et al. Cell Death Differ. 2021 Mar;28(3):968-984.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8727424
figid_alias: PMC7937683__F8
figtype: Figure
redirect_from: /figures/PMC7937683__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7937683__41418_2020_628_Fig8_HTML.html
  '@type': Dataset
  description: a Dsg2 functions as a tumor suppressor through binding between the
    Dsg2 IL domain and cSrc SH2 domain. The EGFR-targeted therapy suppresses EGFR
    signaling pathway. b The loss of Dsg2 in GBC activates cSrc and promotes EGFR
    internalization, which induces resistance to EGFR-targeted therapy. c Combination
    therapy targeting both cSrc and EGFR is a promising therapeutic strategy for GBC
    patients with Dsg2 loss.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egf
  - Dsg2
  - Egfr
  - Sh3
  - Sh2
  - Myo15a
  - Mapk3
  - EGF
  - DSG2
  - EGFR
  - SRC
  - MAPK3
  - ec
  - ics
  - Src64B
  - Fak
  - Akt
  - rl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - mid
  - Dasatinib
---
